Phase IIa study of Laquinimod for the treatment of non-infectious uveitis
Latest Information Update: 06 Dec 2020
At a glance
- Drugs Laquinimod (Primary)
- Indications Uveitis
- Focus Proof of concept; Therapeutic Use
- 24 Nov 2020 According to a Active Biotech media release, Proof-of-principle readout of oral phase 2 study expected in 2023.
- 06 Nov 2020 New trial record
- 05 Nov 2020 According to a Active Biotech media release, the company expect to initiate this study during second half of 2021.